Bereaved Mother Disrupts Film Screening in Netherlands, Confronts Creators
Translated & summarized from 0404 by baba
The story in 5 lines · by baba
- Bereaved mother Sivan Taasa disrupted a film screening in Delft, Netherlands.
- Taasa confronted the filmmakers, questioning their portrayal of collateral damage.
- Audience members responded with hostility towards Taasa.
- The CEO of 'Ad Kan' also faced aggression while attempting to screen a different video.
- The incident occurred during the European premiere of the film.
A screening of a film by Yuval Avraham and Rachel Shor in Delft, Netherlands, was disrupted by Sivan Taasa, a mother whose husband and son were killed in the Hamas attack on October 7. Taasa, accompanied by Avichai Shorshan, CEO of the Israeli NGO 'Ad Kan,' confronted the filmmakers and the audience, questioning the film's narrative. She ascended the stage, asking the audience and creators, "Look me in the eyes. You talk about collateral damage? My husband and son were murdered by Hamas. Where does that appear in your film?"
During Taasa's address, some audience members shouted at her, "We don't care, shame on you, we don't want to hear." Shorshan, who was attempting to project "the horror video" on a mobile projector, also faced aggression from viewers who prevented the screening from continuing. He stated that the "collateral damage to the State of Israel as a result of the false film is unimaginable" and vowed to continue fighting the spread of antisemitism in Europe.
Taasa's husband and son were killed on October 7, and her other children were seriously injured. The film's screening was part of its European premiere. 'Ad Kan' is an organization that aims to expose what it calls false narratives and combat antisemitism.
Read the original at 0404Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
